Sign in or Register   Sign in or Register
  |  

Mouse Anti-MTM1 (AA 1-100) Recombinant Antibody (CBFYM-2744) (CBMAB-M2937-FY)

This product is mouse antibody that recognizes MTM1. The antibody CBFYM-2744 can be used for immunoassay techniques such as: ELISA, IHC, WB.
See all MTM1 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBFYM-2744
Antibody Isotype
IgG2a, k
Application
ELISA, IHC, WB

Basic Information

Immunogen
Partial recombinant corresponding to aa1-100 from human MTM1 (AAH30779) with GST tag. MW of the GST tag alone is 26kD.
Specificity
Human
Antibody Isotype
IgG2a, k
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS, pH 7.2
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Epitope
AA 1-100

Target

Full Name
myotubularin 1
Introduction
This gene encodes a dual-specificity phosphatase that acts on both phosphotyrosine and phosphoserine. It is required for muscle cell differentiation and mutations in this gene have been identified as being responsible for X-linked myotubular myopathy.
Entrez Gene ID
4534
UniProt ID
Q13496
Alternative Names
Myotubularin 1; Phosphatidylinositol-3,5-Bisphosphate 3-Phosphatase; Phosphatidylinositol-3-Phosphate Phosphatase; Myotubular Myopathy 1; Myotubularin; EC 3.1.3.48; EC 3.1.3.95
Function
Lipid phosphatase which dephosphorylates phosphatidylinositol 3-monophosphate (PI3P) and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) (PubMed:11001925, PubMed:10900271, PubMed:12646134, PubMed:14722070).

Has also been shown to dephosphorylate phosphotyrosine- and phosphoserine-containing peptides (PubMed:9537414).

Negatively regulates EGFR degradation through regulation of EGFR trafficking from the late endosome to the lysosome (PubMed:14722070).

Plays a role in vacuolar formation and morphology. Regulates desmin intermediate filament assembly and architecture (PubMed:21135508).

Plays a role in mitochondrial morphology and positioning (PubMed:21135508).

Required for skeletal muscle maintenance but not for myogenesis (PubMed:21135508).

In skeletal muscles, stabilizes MTMR12 protein levels (PubMed:23818870).
Biological Process
Endosome to lysosome transport Source: UniProtKB
Intermediate filament organization Source: UniProtKB
Mitochondrion distribution Source: UniProtKB
Mitochondrion morphogenesis Source: UniProtKB
Muscle cell cellular homeostasis Source: GO_Central
Negative regulation of autophagosome assembly Source: GO_Central
Negative regulation of proteasomal ubiquitin-dependent protein catabolic process Source: Ensembl
Negative regulation of protein kinase B signaling Source: Ensembl
Negative regulation of TOR signaling Source: Ensembl
Phosphatidylinositol biosynthetic process Source: Reactome
Phosphatidylinositol dephosphorylation Source: UniProtKB
Positive regulation of skeletal muscle tissue growth Source: Ensembl
Protein dephosphorylation Source: UniProtKB
Protein transport Source: UniProtKB-KW
Regulation of vacuole organization Source: UniProtKB
Cellular Location
Plasma membrane
Cell membrane
Cytoplasm
Endosome
Late endosome
Other locations
filopodium
ruffle
sarcomere
Note: Localizes as a dense cytoplasmic network (PubMed:11001925). Also localizes to the plasma membrane, including plasma membrane extensions such as filopodia and ruffles (PubMed:12118066). Predominantly located in the cytoplasm following interaction with MTMR12 (PubMed:12847286). Recruited to the late endosome following EGF stimulation (PubMed:14722070). In skeletal muscles, co-localizes with MTMR12 in the sarcomere (By similarity).
Involvement in disease
Myopathy, centronuclear, X-linked (CNMX):
A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers.
Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-MTM1 (AA 1-100) Recombinant Antibody (CBFYM-2744)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare